Pandora, Gap Post R...
Health Care: Drugs
Hospira Inc. (HSP: NYSE)
$35.18 -0.22 | -0.62%
05/23/13 - 04:01 PM ET
683.40K / 1.52M
Vol / Avg. Vol:35.12 / 35.40
Open / Prev. Close:34.93 - 35.32
Today's Range:28.62 - 37.78
52 Wk Range:13.32%
Performance YTD:TheStreet Rating:
Portfolios with HSP
- Portfolio NameUser Type
- Contributor8 Pharma Stocks to Watch
- ProRobert Bruce
- ProRonald Muhlenkamp
- UserFranks
- ContributorTop 20 Stocks With Large In...
- ProJohn Rogers - Ariel Capital...
- ContributorTheStreet Ratings Top-Rated...
- ContributorTop 20 Stocks With Huge Ins...
- UserAberian System, MEDICAL stocks
- Contributor5 Stocks Setting New 52-Wee...
Latest HSP Headlines from TheStreet
- Interesting HSP Put And Call For July 05.20.13 | 06:05 pm
- Synta Is a Run-Up Trade Into ASCO Lung Cancer Data 05.14.13 | 10:05 am
- Hospira Inc. (HSP): Today's Featured Health Care Laggard 05.13.13 | 05:05 pm
- Hospira Becomes #24 Most Shorted S&P 500 Component, Replacing Leggett & Platt 05.10.13 | 03:05 pm
- HSP Makes Bullish Cross Above Critical Moving Average 04.25.13 | 04:04 pm
- Hospira Inc. (HSP): Today's Highlighted Laggard In Health Care 04.04.13 | 05:04 pm
- Hospira Inc. (HSP): Today's Featured Drugs Laggard 03.05.13 | 05:03 pm
- Hospira Rises On Unusually High Volume (HSP) 02.19.13 | 03:02 pm
- Hospira Stock Falls On Unusually High Volume (HSP) 02.13.13 | 11:02 am
- Cramer's 'Mad Money' Recap: The Benefit of Doing Nothing 10.08.12 | 08:10 pm
Press Releases for HSP
- Hospira Reappoints Dr. Sumant Ramachandra Chief Scientific Officer - PR Newswire 05.14.13 | 09:05 am
- Hospira Convenes Its 2013 Annual Meeting Of Shareholders - PR Newswire 05.08.13 | 12:05 pm
- Hospira Unveils Global Device Strategy - PR Newswire 05.01.13 | 07:05 am
- Hospira To Present At Upcoming Investor Conferences - PR Newswire 04.17.13 | 11:04 am
- Hospira Names Matthew R. Stober Senior Vice President Of Operations - PR Newswire 04.15.13 | 04:04 pm
- Hospira To Host Conference Call For First-Quarter 2013 Results - PR Newswire 04.02.13 | 10:04 am
- Hospira Obtains Six Months U.S. Pediatric Exclusivity For Precedexâ¿¢ (dexmedetomidine HCl) Injection - PR Newswire 03.18.13 | 10:03 am
- Hospira Announces Executive Changes - PR Newswire 03.01.13 | 02:03 pm
- Hospira To Present At Upcoming Investor Conferences - PR Newswire 02.05.13 | 10:02 am
- Hospira's TheraDocâ¿¢ Infection Control Assistant Ranked #1 In Its Category In The Latest "Best In KLAS" Report - PR Newswire 01.23.13 | 11:01 am
Partner Headlines for HSP
- Danish pension fund in Death Row protest - Financial Times 03.15.13 | 08:03 pm
- Rival's problems lift Hikma - Financial Times 03.14.13 | 01:03 am
- Watson Pharma Starts New Era As Generic Drug Titan - Investor's Business Daily 11.02.12 | 04:11 pm
- Hospira to Acquire Orchid Facility - Analyst Blog - NASDAQ 08.30.12 | 10:08 pm
- Hospira to Acquire Orchid Facility - Analyst Blog - Zacks 08.30.12 | 06:08 pm
- Rituxan And Its Biosimilar Competitors - Seeking Alpha 07.30.12 | 09:07 am
- Hospira Second Quarter Earnings Sneak Peek - Wall St. Cheat Sheet 07.27.12 | 02:07 am
- Dr. Reddy's & Merck Serono Team Up - Analyst Blog - Zacks 06.08.12 | 06:06 pm
- Significant Upside Of About 25% For Baxter, Covidien - Seeking Alpha 02.24.12 | 05:02 pm
- Biosimilars: The Next Big Thing - Analyst Blog - Zacks 01.13.12 | 05:01 pm
